Shanghai, China

Lihua Xie

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Equinox Sciences, LLC. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lihua Xie. Retrieved from https://idiyas.com/inventor/lihua-xie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lihua Xie: Innovator in Pharmaceutical Chemistry

Introduction

Lihua Xie is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of kinase inhibitor compounds. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Lihua Xie's latest patents include the invention of polymorphic forms of a kinase inhibitor compound, along with pharmaceutical compositions containing the same. The preparation method disclosed in these patents allows for the production of various crystalline forms of the compound with high purity, suitable for large-scale production. The crystalline forms exhibit good stability and maintain a purity decrease of less than 2% for their main ingredient. This advancement is crucial for ensuring the efficacy and safety of pharmaceutical products.

Career Highlights

Throughout his career, Lihua Xie has worked with notable companies such as Equinox Sciences, LLC and Betta Pharmaceuticals Co., Ltd. His experience in these organizations has further honed his skills in pharmaceutical research and development.

Collaborations

Lihua has collaborated with various professionals in the field, including Congxin Liang, who has contributed to his research endeavors.

Conclusion

Lihua Xie's innovative work in the pharmaceutical industry, particularly in the development of kinase inhibitor compounds, highlights his significant impact on medical science. His patents reflect a commitment to advancing drug development and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…